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ABSTRACT 
The maior heat shock protein, HSP70, protects cells from a 
variety o f  stress ful stimuli, while c-m_yc protein a llegedly 
stimu lates expression o f  HSP70 by transacting on the HSP70 
promotor. This study was aimed at correlating expression o f  
HSP70 with that o f  c-myc protein in benign and malignant breast 
lesions. For this purpose, the indirect immunoperoxidase and 
immuno blotting techniques using monoclonal antibodies were 
employed. Fresh frozen sections were prepared from five 
fibroadenomas and 59 breast carcinomas. Immunohistochemically, 
both proteins were localized in the nuclei and/or cytoplasm o f  
neoplastic and nonneoplastic epithelial cells. Expression o f  
HSP70 and c-myc protein was comparable in malignant cells o f  37 
{63%) carcinomas. I n 1 7 c 2 9% ) car c i n om as , c -mY _c p r o t e i n 
expression predominated over HSP70 while in 5 (8%) carcinomas 
HSP70 was predominant. All five fibroadenomas and most 
nonneoplastic epithelial cells adjacent to cancer showed strong 
reactivities o f  both proteins. Immunoblot analysis for HSP70 
revealed a clear single band in the extract o f  tumors with strong 
HSP70 staining, but no or faint bands were seen in the extract o f  
immunohistochemically HSP70-negative carcinomas. The current 
study, for the first time, demonstrated the expression o f  HSP70 
i n human c an c e r c e I I s j_n y i V:.Q. • T h e d i s c r e pan c y i n ex p r e s s i o n o f 
both proteins in a certain percentage o f  breast carcinomas 
suggests the presence o f  mechanisms o f  HSP70 production not 
involving the c-myc protein-triggered promotor pathway. 
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INTRODUCTIO 
Exposure o f  cells to environmental stress induces a se1·ies 
o f  heat shock proteins C HSPs) . These stresses include 
nonphysiolog 1c t.emperature1-10) , exposure tu drugs1) , induction 
by mitotic reagents10-12>, and starvation o f  glucose9) and 
HSPs are known to be encoded by members o f  a multigene serum13>. 
f ami l y14) . The predominant and highly conserved form o f  HSPs is 
HSP70 o f  approximately 70 kDa in molecular size15>. In most 
mammalian cells, there are two major forms u f  HSP70. A 
constitutive form is 73 kDa while 72 kDa protein is heat­
inducible and is also produced by exposure to nonphysiologic 
stresses5>. These two proteins are encoded by di f ferent 
genes1) , whereas the 73 and 72 kDa proteins are chemically and 
immunologically similar2•3•5•8>. HSP70s are known to be 
distributed in both the cytoplasm and nuclei o f  cultured cells, 
and are allegedly concentrated in nuclei, particularly in 
nucleoli by heat shock3•4 •6>. Following return to heat shock­
treated cells to normal growth temperature, both the synthesis 
o f  72 kDa stress protein and its nucleolar staining diminish3>. 
The association o f  HSP70 with the damaged cytoskeletal structure 
in the cytoplasm has also been documentedlS-lB>. HSP70s protect 
cells from stress ful environmental stimuli although the exact 
mechanisms o f  protection are not clear at present15>. HSP-70-
like proteins are also known to be crucial for normal cell 
growth 7 > . 
The c-mYQ oncogene and oncoprotein show a high degree o f  
evolutional conservation19>. The oncogene product is expressed 
in nuclei in certain phases o f  cell cycle and cell 
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di f ferentiation 20- 23> . Recent ly, Ariga et a1. 2 4> showed that 
c-myc protein is a sequence-speci fic factor involved both in 
initiation o f  DNA rep lication and in regulation o f  RNA 
transciiption. The product of a rearranged mouse c-myc gene is 
capable o f  stimulating expression o f  chimeric genes containing a 
Drosophila HSP70 promotor region and its 5'-flanking sequence 25>. 
The c-�yc protein also stimulates to elevate the level o f  
appropriately initiated protein expression from the human HSP70 
promo t o r 2 6 ) , and he a t s h o c k a I s o i ncr e as e s the r a t e o f c .=_m_IT 
protein synthesis 27) . So far, ampli fication and enhanced 
expression o f  c-myc oncogene have been demonstrated in human 
breast carcinoma tissues and cell lines 28-3 2) . 
Our current study was aimed at elucidating the expression o f  
HSP70 and the correlation of HSP70 localization with c-m_y9 
protein localization in benign and malignant human breast tumors. 
Analyses were per formed by immunohistochemical and immunoblotting 
techniques using monoclonal antibodies. 
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M ATERIALS AND METHODS 
Sixty- four surgically resected breast tumors <59 carcinomas 
and 5 fibroadenomas) were i mmediately frozen a fter embedding in 
O. C. T. compound <Miles Inc. , Elkhart, I N, USA) . Their histologic 
types were determined on the basis o f  the criteria proposed by 
the Japan Mammary Cancer Society33>. The carcinomas were further 
classi fied into three groups by nuclear pleomorphism a fter Elston 
et ai34>, as shown in the footnote o f  Table 2. Fresh frozen 
sections, 6 urn thick, were cut and fixed in a 1: 1 mixuture o f  
ethanol and acetone at 4°C for 10 minutes and in 10% formalin at 
room temperature for 30 minutes for c-myc protein. 
Immunostain 1ng was per formed using the indirect immunoperoxidase 
technique. A mouse monoclonal HSP70 antibody, RPN1197, from 
Amersham International C Amersham Bucks, U. K. ) ,  speci fically 
recognizes 72 kDa-HSP70 without reactivity to any other kinds o f  
HSPs and related proteins8>. A mouse �=mLc monoclonal antibody, 
O M-11-906, from Cambridge Research Biochemicals (Cambridge, 
U . K . ) , rea c t s w i t h c -_m_y__G pro t e i n s f r o rn h u man < p 6 2 c-my c ) and m o us e 
(p64c-myc) and (p66c-myc) ,  but not with chicken Cp110c-myc) and 
N=myc protein35>. Horseradish peroxidase-labeled antimouse Ig IG 
were from Amersham International. Peroxidase activity was 
located by dipping sections in 0. 05 M Tris-HCl solution, pH 7. 6, 
containing 25 mg% diaminobenzidine and 0. 003% hydrogen peroxide 
for 5 minutes. Sections were counterstained with 5% methyl green 
in 0. 1 M Verona! acetate bu f fer, pH 4. 0. Normal mouse serum at 
dilution o f  1: 100 was used as a negative staining control. 
Antigen localization patterns were evaluated as either nuclear 
predominance, cytoplasmic predominance or both nuclear and 
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cytoplasmi c locali zati on. The degree of anti gen expressi on was 
scoied from <-> to (++). accordi ng to the number of cells that 
were stai ned positive l y  i n  the nuclei and/or cytoplasm, namely, 
-: negati ve or equivocal, +: less than 50% of cells posi ti ve, and 
++: more than 50% of cells posi ti ve. 
Porti ons of the fresh nonnecroti c cancer tissue were stored 
at -70°C for i mmunoblot analysi s. Representative tissue samples 
(0. 1 g) were homogenized wi th 0.9 ml of 20 mM Tri s-HCl buffer, p H  
7. 6, containi ng 1 mM ethylenediamine tetraaceti c aci d CEDTA) and 
50 mM phenylmethyl sulfonylfluoride. The homogenates were mi xed 
with the same volume of 1 20 mM Tris-HCl, p H  6. 8, contai ning 4% 
sodi um dodecyl sulphate (SDS) , 40% glycerol, 10 mM EDTA and 5% 2-
mercaptoethanol i n  Eppendorf's microcentri fuge tubes and then 
placed i n  boiling water for 5 mi nutes. After centri fugati on at 
14, 000 rpm for 10 minutes, 5 ul of the supernatant were applied 
to SDS-polyacrylamide gel electrophoresis according to the method 
of Laemmli36>. Protei ns were blotted to a nitrocellulose filter 
(Schleicher & Schuell, Dassel, W. Germany) by the method of 
Towbi n et a1. 37> and i mmunostai ned by the indi rect 
immunoperoxidase method. 
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RESULTS 
HSP70 and c-myc p1· utein were localized in the nuclei and/or 
cytoplasm C Figs. 1-5). Control sections incubated with normal 
mouse serum were totally unstained. All 5 fibroadenomas, as well 
as most nonneoplastic mammary epithelial cells adjacent to 
cancer. showed strong positivity (++) for both substances, mainly 
in the nuclei. HPS70 immunoreactivity was demonstrated in 44 
<75%) carcinomas; (++) in 3 2  (54%) tumors and (+) in 1 2  ( 20%) 
CTable 1). Fi fteen ( 25%) carcinomas were negative or equivocal 
for HSP70. In 7 (1 2%) carcinomas the cytoplasm was the main site 
o f  HSP70 localization <Table 2). Thirty-one (53%) tumors 
expressed HSP70 in both the nuclei and cytoplasm. Nuclear HSP70 
staining was predominant in 6 (10%). Heterogenous (mosaic) 
staining patterns o f  HSP70, in which positivity varied from cell 
to cell, were demonstrated in 11 C19%) carcinomas C Fig. 5). When 
the tumors were graded according to the degree o f  nuclear atypia, 
grade 3 atypia was seen in 5 carcinomas, grade 2 atypia in 20, 
and grade 1 in 34 (Table 2). Characteristically, tumors with 
HSP70 localized mainly in the nuclei tend to accompany less 
nuclear atypia CFig. 1) and four o f  five tumors with grade 3 
atypia showed negative staining for HSP70 CFig. 3). A similar 
tendency was observed when the pattern o f  c�myc protein 
expression was correlated with nuclear atypia in cancer cells 
<Table 3). The carcinomas were histologically classi fied into 5 2  
invasive ductal carcinomas (7 papillotubular carcinomas, 13 
solid-tubular carcinomas and 3 2  scirrhous carcinomas), 3 mucinous 
carcinomas, 2 medullary carcinomas and 2 invasive lobular 
carcinomas. No signi ficant correlation was seen between the 
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expression pattern of HSP70 or c-myc protein and the histologic 
typing. 
c-myc protein immunoreactivity was (++) in 40 <68%) 
carcinomas, (+) in 1 2  ( 20%) , and (-) in 7 <1 2%) . HSP70 was 
exclusively expressed in epithelial cells while c�myc protein was 
demonstrated in both epithelial and stromal cells. Staining 
intensity o f  HSP70 in cancer cells was o ften weaker than that in 
nonneoplastic epithelial cells adjacent to the cancer tissue 
CFig. 1) . In 37 <63%) carcinomas, expression o f  HSP70 and c-myc 
protein was comparable, as shown in Figure 2 and Table 1. In 17 
( 29%) carcinomas. �:-miT protein expression predominated over 
HSP70 CFigs. 1 and 3) while in 5 (8%) carcinomas HSP70 was 
predominant C Fi g. 4) . 
Results o f  the immunoblot analysis using cancer extracts 
corresponded well with those o f  immunostaining. HSP70 
immunoreactivity was visualized as a clear single band around the 
molecular weight o f  70, 000 dalton on the membrane filter C Fig. 
6). The bands were not visible or faint in the extract o f  
carcinomas immunohistochemically negative for HSP70 (Lanes 1 and 
2) . The extract o f  breast carcinomas strongly immunostained for 
HSP70 showed a dense single band o f  HSP70 (Lanes 3 and 4) .  
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D ISC USS ION 
HSPs consist u f  a protein family highly conserved during the 
phylogenetic development15). HSP70, the main member o f  this 
family, is known to be crucially important fur sel f-protection 
against a variety o f  stresses1-13) and for normal growth7). and 
its expression is allegedly controlled by the c-myc protein 
transacting on the HSP70 promotor 25, 26>. By using a monoclonal 
antibody to human HSP70, we demonstrated immunoreactive HSP70 in 
frozen sections o f  human breast tissues, and the expression o f  
HSP70 was compared with that o f  c-myG protein. Both HSP70 and c­
myc protein were localized in the nuclei and/or cytoplasm o f  
benign and malignant epithelial cells. Speci ficity o f  
immunostaining was con firmed by negative staining with normal 
mouse serum and by the immunoblotting technique for HSP70. The 
discordant expression o f  both substances were noted in a 
considerable percentage o f  cancer tissues, with e-m� protein 
expression being predominant in 29% o f  carcinomas and HSP70 
predominant in 8% o f  carcinomas. These data suggest the presence 
o f  mechanisms o f  HSP70 expression not involving the c�myc 
protein-triggered promotor pathway in human breast carcinomas. A 
heterogenous staining pattern o f  HSP70 observed in 19% o f  tumors 
suggested varied levels o f  expression o f  this protective 
substance in individual cancer cells with in a single tumor 
tissue. 
No studies have so far been focused on the expression o f  
HSP70 in human cancer cells in _yjvo. To our knowledge, only two 
reports have described localization o f  immunoreactive HSP70 in 
nonneoplastic human tissues; one in atherosclerotic lesions38> 
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and another in alcoholic liver d 1sease18>. Since nuclear and 
nuclec lar localization of HSP70 has been observed under the 
stress ful Cheat-shocked) conditions in cultured cells3·4•6>, 
HSP70 might function as an important cell protector within the 
nucleus. In fact, HSP70 has a ca pacity to bind to 
nucleotides3•4> . The physiologic roles o f  HSP70 in the cytoplasm 
have also been presentedl6-18>. 
In the current study, nuclear localization o f  HSP70 was 
o ften seen in benign mammary epithelial cells and in breast 
carcinomas with low nuclear atypia. In contrast, breast 
carcinomas with high nuclear atypia frequently lacked HSP70 
expression. These findings suggest that the pattern o f  HSP70 
localization might re flect the heat shock-resistant status o f  
cancer tissues. In this sense. the susceptibility to 
thermotherapy39•40> is a good target o f  study in relation to the 
HSP70 expression and its intracellular localization pattern in 
breast cancer. Although it has been shown that thermotherapy is 
e f fective irrespective o f  the histologic types o f  cancer41>, no 
detailed examination has been per formed in view o f  the 
relationship between the HSP70 status and thermoresistance o f  
cancer. It is supposed that breast cancer with high atypia is 
susceptible to thermotherapy because o f  its frequent lack o f  
HSP70 expression. This hypothesis is now being our target o f  
clinical investigation. 
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Table 1. Immunohistochemical reactivit� of HSP70 and c-m�c 
protein in 59 breast carcinomas 
HSP70 
+ ++ Total 
c-myc 5 0 2 7 
protein + 4 5 3 12 
++ 6 7 27 40 
Total 15 12 32 59 
negative or equivocal 
+: less than 50% of cancer cells positive 
++: more than 50% of cancer cells positive 
cf. All five fibroadenomas showed intensive 
reactivity (++) of both substances. 
Table 2. Patterns of HSP70 immunostaining 1n breast carcinomas 
ln _[_elation to nuclear atypia 
Pattern of Nuclear at;ip.iaa> 
HSP70 staining grade 1 grade 2 grade 3 
Nuclear predominance 5 1 0 
Cytoplasmic predominance 3 4 0 
Both nuclear & cyto plasmic 22 8 1 
Negative 4 7 4 
Total 34 20 5 
a>Grade of nuclear a ty pia was determined according to the 
following criteria pro posed by Elston et al.341 
grade 1: Little variation seen in nuclear size 
Total 
6 
7 
31 
15 
59 
grade 2: A moderate degree of variation seen in nuclear size 
grade 3: Marked vari ation seen in nuclear size and shape 
Table 3. Patterns of c-myc protein immunostaining 1n 
breast carcinomas in relation to nuclear atypia 
Pattern of Nuclear at:tEia 
c-m�c Eroteln staining grade 1 grade 2 grade 3 
Nuclear predominance 19 2 1 
Cyto plasmic predominance 2 1 1 
Both nuclear & cyto plasmic 11 14 1 
Negative 2 3 2 
Total 34 20 5 
Total 
22 
4 
26 
7 
59 
Figure 1. Comparative immunostaining of c-myc protein 
<B:++J and HSP70 CC:+) in a grade 1 scirrhous carcinoma and 
adjacent noncancer breast tissue CxlOO, A:H&E). Both substances 
are l ocalized mainly in nuc l ei. Benign ductal ce l l s show strong 
nuclear immunoreactivity for both substances. The cancer ce l l s 
show weaker staining of HSP70 when compared w1th the normal 
mamma1y lobule. c-myc protein IS positive also in nuc l ei of 
mesenchymal cells. 
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Comparative immunostaining o f  G_-m_y..Q protein 
i 
·• 
<B:++) and HSP70 <C:++) in a grade 1 seirrhous carcinoma Cxl50, 
A: H&E) . Note nuclear and mesenchymal staining of c-myc protein 
and cytoplasmic staining u f  HSP70. 
Figure 3. Comparative immunostaining of c-myc protein 
<B:++) and HSP70 CC:-> 1n a grade 3 papillotubular carcinoma 
<x200, A:H&E>. HSP70 staining is negligible in contrast to 
active nuclear exp1ession o f  c-_JUYG protein. Endogenous 
peroxidase activity is seen in granulocytes infiltration around 
the tumor nests. 
IB 
F i g u r e 4 . Co m p a r a t i v e i m m u n o s t a i n i n g u f c-mY.G p r o t e i n ( B : -) 
and HSP70 <C:++) i n  a grade 2 sci rrhous carci noma Cx75. A:H8E) . 
In this cancer. HSP70 i s  predomi nant over equi vocally stai ned c­
m_yc protei n. HSP70 i s  observed i n  the cytoplasm. 
A B 
Figure 5. Heterogenous (mosaic) expression o f  HSP70 in two 
grade 2 scirrhous carcinoma. A proportion o f  cells are positive 
for HSP70 in the cytoplasm C A, x300) or in nuclei (B, x150) . 
Noncancerous ducts are strongly immunoreactive for HSP70 CB) . 
Figure 6. 
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Immunoblot analysis o f  breast carcinoma extracts 
for HSP70. Lanes 1 & 2: carcinomas immunohistochemically 
negative or equivocal for both HSP70 and c-_myc protein. Lanes 3 
& 4 :  carcinomas strongly positive by immunostaining for both 
HSP70 and c�my� protein. Results o f  immunoblotting well 
correspond tu those o f  immunohi stochemical staining. The weak 
band seen in lane 1 might re flect the admixture o f  noncancerous 
ducts in the cancer tissue as shown in Figure 5B. 
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